Is it time for geriatricians to get on board with lecanemab? Jason Karlawish and Ken Covinsky
GeriPal
DECEMBER 15, 2022
On today’s podcast we talk with Jason Karlawish, who we’ve had on previously talking about his book The Problem of Alzheimer’s and with Aaron Kesselhim, to discuss FDA approval of Aducanumab , as well as frequent guest and host Ken Covinsky. . Summary Transcript Summary. But wait, there’s a shiny new anti-amyloid drug, lecanemab! (No
Let's personalize your content